Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

Status:
Completed

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.

Phase 2

Albireo